Pioglitazone Hydrochloride Tablet
Product Images NDC 84677-026

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Pioglitazone Hydrochloride (NDC 84677-026). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gsms, Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Containerlabel15mg500cc (Containerlabel15mg500cc)

Containerlabel15mg500cc (Containerlabel15mg500cc)
Pioglitazone Tablets USP 15 mg label showing the product name, strength, and tablet count of 500 tablets. The label specifies the 15 mg strength and includes text about storage and handling instructions. Marketed by GSMS, Incorporated and manufactured by CorePharma, LLC. The label includes a barcode and a serialization area.*
FDA Label Image

Containerlabel30mg500cc (Containerlabel30mg500cc)

Containerlabel30mg500cc (Containerlabel30mg500cc)
The label for Pioglitazone Tablets, USP 30 mg oral tablets shows key information including the NDC 84677-027-05, the requirement to dispense with a Medication Guide, and that the package contains 500 tablets. It states the product is marketed by GSMS, Incorporated and manufactured by CorePharma, LLC. Storage instructions and warnings to keep out of reach of children are also present.*
FDA Label Image

Containerlabel45mg500cc (Containerlabel45mg500cc)

Containerlabel45mg500cc (Containerlabel45mg500cc)
Label for Pioglitazone Tablets USP 45 mg oral tablets in a 500-count container. The label includes dosage information, storage instructions, and warnings to keep out of children's reach. Marketed by GSMS, Incorporated and manufactured by CorePharma, LLC. The label features the NDC 84677-028-05 and a barcode.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A line graph showing mean values over a 26-week period for placebo and three dosage strengths (15 mg, 30 mg, 45 mg) of Pioglitazone Hydrochloride tablets. The x-axis represents weeks, and the y-axis represents mean values. Different lines distinguish placebo and each dose level.*
FDA Label Image

Pioglitazone-str (Pioglitazone Str)

Pioglitazone-str (Pioglitazone Str)
Chemical structure of Pioglitazone Hydrochloride, showing its molecular arrangement with characteristic rings and functional groups including a thiazolidinedione moiety and hydrochloride salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.